Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lineage Cell Therapeutics (LCTX) Tax Rate (2019 - 2023)

Lineage Cell Therapeutics' Tax Rate history spans 5 years, with the latest figure at 29.05% for Q1 2023.

  • For Q1 2023, Tax Rate changed N/A year-over-year to 29.05%; the TTM value through Dec 2023 reached 7.74%, down 4850.0%, while the annual FY2025 figure was 7.69%, N/A changed from the prior year.
  • Tax Rate reached 29.05% in Q1 2023 per LCTX's latest filing, up from 0.64% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 262.3% in Q4 2019 to a low of 9.7% in Q3 2022.
  • Average Tax Rate over 4 years is 37.09%, with a median of 6.04% recorded in 2021.
  • The largest YoY upside for Tax Rate was -2114bps in 2022 against a maximum downside of -2114bps in 2022.
  • A 4-year view of Tax Rate shows it stood at 262.3% in 2019, then tumbled by -96bps to 11.44% in 2021, then crashed by -94bps to 0.64% in 2022, then surged by 4407bps to 29.05% in 2023.
  • Per Business Quant, the three most recent readings for LCTX's Tax Rate are 29.05% (Q1 2023), 0.64% (Q4 2022), and 9.7% (Q3 2022).